MAPT and Alzheimer disease: While little existing work has employed non-Gaussian dMRI to detect AD pathology, one previous in-vivo human study reported a negative finding for RTOP in which there was no correlation with PET-markers of AD (Aβ and tau) (Spotorno et al., 2022).